StemCell Institute Inc. 7096.T Stock
1792 JPY
{{ price }}
-0.720222%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Japan
Exchange
Tokyo
Market Cap
18.36B JPY
LOW - HIGH [24H]
1792
-
1805 JPY
VOLUME [24H]
3.4K JPY
{{ volume }}
P/E Ratio
65.30
Earnings per share
27.44 JPY
StemCell Institute Inc. Price Chart
StemCell Institute Inc. 7096.T Financial and Trading Overview
| StemCell Institute Inc. stock price | 1792 JPY |
| Previous Close | 2511 JPY |
| Open | 2497 JPY |
| Bid | 2535 JPY x N/A |
| Ask | 2550 JPY x N/A |
| Day's Range | 2497 - 2541 JPY |
| 52 Week Range | 2052 - 3285 JPY |
| Volume | 2K JPY |
| Avg. Volume | 27.73K JPY |
| Market Cap | 25.91B JPY |
| Beta (5Y Monthly) | 0.733028 |
| PE Ratio (TTM) | 117.518585 |
| EPS (TTM) | 27.44 JPY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
7096.T Valuation Measures
| Enterprise Value | 22.36B JPY |
| Trailing P/E | 117.518585 |
| Forward P/E | 32.38156 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 11.908847 |
| Price/Book (mrq) | 10.837936 |
| Enterprise Value/Revenue | 10.274 |
| Enterprise Value/EBITDA | 53.231 |
Trading Information
StemCell Institute Inc. Stock Price History
| Beta (5Y Monthly) | 0.733028 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 3285 JPY |
| 52 Week Low | 2052 JPY |
| 50-Day Moving Average | 2917.14 JPY |
| 200-Day Moving Average | 2600.5 JPY |
7096.T Share Statistics
| Avg. Volume (3 month) | 27.73K JPY |
| Avg. Daily Volume (10-Days) | 16.85K JPY |
| Shares Outstanding | 10.25M |
| Float | 2.33M |
| Short Ratio | N/A |
| % Held by Insiders | 77.87% |
| % Held by Institutions | 4.76% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 10.24% |
| Operating Margin (ttm) | 14.43% |
| Gross Margin | 64.19% |
| EBITDA Margin | 19.30% |
Management Effectiveness
| Return on Assets (ttm) | 3.52% |
| Return on Equity (ttm) | 9.81% |
Income Statement
| Revenue (ttm) | 2.18B JPY |
| Revenue Per Share (ttm) | 188.77 JPY |
| Quarterly Revenue Growth (yoy) | 17.29% |
| Gross Profit (ttm) | N/A |
| EBITDA | 420M JPY |
| Net Income Avi to Common (ttm) | 223M JPY |
| Diluted EPS (ttm) | 21.52 |
| Quarterly Earnings Growth (yoy) | 50.00% |
Balance Sheet
| Total Cash (mrq) | 3.28B JPY |
| Total Cash Per Share (mrq) | 320.11 JPY |
| Total Debt (mrq) | 0 JPY |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.353 |
| Book Value Per Share (mrq) | 233.347 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of StemCell Institute Inc.
| Country | Japan |
| State | N/A |
| City | Tokyo |
| Address | 5-22-10, Shinbashi |
| ZIP | 105-0004 |
| Phone | 81 3 5408 5279 |
| Website | https://www.stemcell.co.jp |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 92 |
StemCell Institute Inc. engages in the stem cell banking business in Japan. It is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. The company was incorporated in 1999 and is headquartered in Tokyo, Japan.
Q&A For StemCell Institute Inc. Stock
What is a current 7096.T stock price?
StemCell Institute Inc. 7096.T stock price today per share is 1792 JPY.
How to purchase StemCell Institute Inc. stock?
You can buy 7096.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for StemCell Institute Inc.?
The stock symbol or ticker of StemCell Institute Inc. is 7096.T.
Which industry does the StemCell Institute Inc. company belong to?
The StemCell Institute Inc. industry is Biotechnology.
How many shares does StemCell Institute Inc. have in circulation?
The max supply of StemCell Institute Inc. shares is 10.25M.
What is StemCell Institute Inc. Price to Earnings Ratio (PE Ratio)?
StemCell Institute Inc. PE Ratio is 65.30612000 now.
What was StemCell Institute Inc. earnings per share over the trailing 12 months (TTM)?
StemCell Institute Inc. EPS is 27.44 JPY over the trailing 12 months.
Which sector does the StemCell Institute Inc. company belong to?
The StemCell Institute Inc. sector is Healthcare.